Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
By LabMedica International staff writers Posted on 10 Aug 2015 |
Image: The DRG Renin (Active) ELISA Kit (Photo courtesy of DRG International).
A new ELISA test that measures levels of active renin in human EDTA plasma has been available for inspection at Booth 819 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).
Measurement of levels of active renin in the blood is useful for diagnosing certain types of hypertension. DRG International (Springfield, NJ, USA) has produced a solid phase "sandwich" ELISA kit that is accurate in the range of 0.8 to 128 picograms per milliliter. The assay uses 50 microliters of EDTA plasma and requires about 3 hours and 15 minutes to perform.
The DRG Renin (Active) ELISA Kit can also effectively detect hypertension in pregnancy. Early discovery of hypertension in the expectant mother opens up a much more effective array of treatment methods for the patient.
“The DRG Renin (Active) ELISA Kit allows research laboratories to quickly and easily measure for renin,” said Dr. Cyril E. Geacintov, founder, president, and CEO of DRG International. “The accuracy of our test has made it the top choice of researchers in the field and its applications continue to grow.”
Related Links:
2015 AACC Annual Meeting & Clinical Lab Expo
DRG International
Measurement of levels of active renin in the blood is useful for diagnosing certain types of hypertension. DRG International (Springfield, NJ, USA) has produced a solid phase "sandwich" ELISA kit that is accurate in the range of 0.8 to 128 picograms per milliliter. The assay uses 50 microliters of EDTA plasma and requires about 3 hours and 15 minutes to perform.
The DRG Renin (Active) ELISA Kit can also effectively detect hypertension in pregnancy. Early discovery of hypertension in the expectant mother opens up a much more effective array of treatment methods for the patient.
“The DRG Renin (Active) ELISA Kit allows research laboratories to quickly and easily measure for renin,” said Dr. Cyril E. Geacintov, founder, president, and CEO of DRG International. “The accuracy of our test has made it the top choice of researchers in the field and its applications continue to grow.”
Related Links:
2015 AACC Annual Meeting & Clinical Lab Expo
DRG International
Latest Immunology News
- AI Predicts Tumor-Killing Cells with High Accuracy
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form